Concomitant inhaled corticosteroid resensitises cardiac β2-adrenoceptors in the presence of long-acting β2-agonist therapy

European Journal of Clinical Pharmacology

Volumn 54, Issue 5, 1998, Pages 377-381

  Aziz, I ^a   McFarlane, L C ^a   Lipworth, B J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Budesonide; Eformoterol; Salbutamol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BUDESONIDE; FORMOTEROL FUMARATE; PLACEBO; SALBUTAMOL;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; INHALATIONAL DRUG ADMINISTRATION; NORMAL HUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; BRONCHODILATOR AGENTS; BUDESONIDE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ETHANOLAMINES; FEMALE; HEART RATE; HUMANS; HYDROCORTISONE; MYOCARDIUM; PLACEBOS; POTASSIUM; RECEPTORS, ADRENERGIC, BETA-2; SENSITIVITY AND SPECIFICITY;

EID: 0031876734     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050478     Document Type: Article

References (22)

1. British Thoracic Society (1997) Guidelines for the management of asthma. Thorax 52: S1-S21
2. Grove A, Lipworth BJ (1995) Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet 346: 201-206
3. Newnham DM, McDevitt DG, Lipworth BJ (1994) Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma. Am J Med 97: 29-37
4. 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients. Thorax 50: 497-504
5. Kiely DG, Cargill RI, Grove A, Struthers AD, Lipworth BJ (1995) Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol. Thorax 50: 1062-1066
6. 2-adrenergic receptors in vivo. J Clin Invest 96: 99-106
7. 2-adrenoceptor subsensitivity induced by formoterol. Br J Clin Pharmacol 42: 654P-655P
8. Tan KS, Grove A, MacLean A, Gnosspelius Y, Lipworth BJ (1997) Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. Am J Respir Crit Care Med 156: 28-35
9. 2-adrenoceptor function in asthmatic patients. Chest 109: 343-347
10. 2-adrenoceptor function in asthmatic subjects. Br J Clin Pharmacol 44: 505-508
11. Ellul-Micallef R, Fenech FF (1975) Effects of intravenous prednisolone in asthmatics with diminished adrenergic responses. Lancet 2: 1269-1270
12. 2-Adrenergic resistance in normal human airways. Lancet 2: 375-377
13. 2-adrenergic tolerance in mild asthma. Thorax 53: 110-113
14. 2-sensitivity in alveolar macrophages despite corticosteroid treatment. Am J Respir Crit Care Med 153: 576-581
15. Hadcock JR, Williams DL, Malbon CC (1989) Physiological regulation at the level of mRNA: analysis of steady-stale levels of specific mRNAs by DNA-excess solution hybridisation. Am J Physiol 256: C457-465
16. 2-Adrenoceptor desensitisation in cultured human airway smooth muscle. Clin Sci (Colch) 84: 151-157
17. Arnold JMO, McDevitt DG (1986) Reflex vagal withdrawal and the haemodynamic response to intravenous isoproterenol in the presence of beta-antagonists. Clin Pharmacol Ther 40: 199-208
18. 2-adrenoceptor blockade. Br J Clin Pharmacol 28: 95-102
19. 2-adrenoceptors in the human heart. Circ Res 65: 546-553
20. 2 activity of inhaled fenoterol and salbutamol in normal subjects. Thorax 49: 656-658
21. Jennings BH, Andersson KE, Johansson SA (1991) Assessment of systemic effects of inhaled glucocorticoids: comparisons of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol 40: 77-82
22. 2-adrenoceptor down-regulation in patients receiving regular formoterol. J Allergy Clin Immunol 101 [Suppl. Part 2)]: S152